US approval for Shire’s Vyvanse
February 28, 2007Sales and Marketing
Shire and New River Pharmaceuticals have been given the green light by the FDA to market anti-ADHD drug Vyvanse. Shire, …
Helping UK pharma communicate
February 28, 2007Medical Communications, Sales and Marketing HCA, assocation, public relations
The Healthcare Communications Association (HCA), which aims to promote excellence and best practice within pharmaceutical industry communications, has reached its …
Radical overhaul of NHS prescription drug prices recommended
February 20, 2007Sales and Marketing pricing
The Office of Fair Trading wants to reform the way prescription medicines are priced to reflect the benefits they bring …
Learning from Northwick Park
February 19, 2007Research and Development UK, biotech, clinical trials, drug safety
In December 2006, the official report on the Northwick Park incident was published. Although not the end of the affair, …
Doctors attack ‘nonsensical’ NHS cost-cutting
February 19, 2007The British Medical Association has branded as "nonsensical" the situation whereby hospitals delay routine operations because of financial problems.The doctors' …
Pfizer to submit evidence to NICE inquiry
February 16, 2007Sales and Marketing
Pfizer has confirmed that it is to submit evidence to a forthcoming inquiry into the workings of NICE.The Commons Health …
Sanofi-Aventis growth stifled by Plavix and price cuts
February 15, 2007Sales and Marketing
Figures show that Sanofi-Aventis continued to grow in 2006, despite its complaints about pressure in the US from generic manufacturers …
New HIV therapy to be fast-tracked
February 15, 2007Research and Development
A new treatment for HIV is to be fast-tracked in Europe and the US.Pfizer's new compound maraviroc is to receive …
UK biotech consortium wins major grant for cutting-edge gene therapy
February 14, 2007Research and Development
The EU has granted London-based Ark Therapeutics £1.65 million to fund research into using insect-derived viruses for producing genetic medicines.Ark …
UK pharma and government launch new collaboration
February 14, 2007Research and Development
A collaboration between GlaxoSmithKline, Boehringer Ingelheim, Pfizer and East Lincolnshire PCT has been heralded as the future of healthcare in …
NICE set to appraise obesity treatment Accomplia
February 14, 2007Sales and Marketing
Sanofi-Aventis' obesity treatment Acomplia (rimonabant) will be among the drugs appraised by NICE in its latest works programme. With an …
New anti-clotting antibody enters trials
February 12, 2007Research and Development, Sales and Marketing
European biotech companies ThromboGenics and BioInvent are to start a phase I trial of a new drug which could prove …
Flexing pharma’s competitive muscles
February 12, 2007Sales and Marketing sales, strategy
It is universally acknowledged, almost to the point of cliche, that pharmaceutical companies operate in a highly competitive environment. Ensuring …
GlaxoSmithKline plans five launches for 2007
February 9, 2007Sales and Marketing GSK
GlaxoSmithKline is planning to launch five new products in 2007, bringing to an end a long period for the company …
Cholesterol drugs boost Schering-Plough
February 9, 2007Sales and Marketing Merck, Schering-Plough
A 60% increase in sales of its cholesterol drugs franchise has helped Schering-Plough to post strong growth for 2006.Ezetrol and …
3,000 job losses to help AZ maintain profits and invest in R&D
February 9, 2007Sales and Marketing AZ
AstraZeneca has indicated its plans to shed 3,000 jobs will mainly involve redundancies at its manufacturing facilities, in a renewed …
Momentum growing at specialists Archimedes as lead enters phase III
February 9, 2007Research and Development
Specialist pharmaceutical company Archimedes has reached a vital stage in its plans for growth as its lead product enters phase …
Go-ahead for free prescriptions in Wales despite warnings
February 9, 2007Sales and Marketing NHS, Wales
Wales is set to abolish all NHS prescription charges to patients in a move intended to allow fairer access to …
Arrow purchase adds another string to AZ’s biotech bow
February 9, 2007Research and Development
AstraZeneca has bought London-based Arrow Therapeutics for $150 million (£76 million) in cash, adding to a long list of recent …
Novartis set for ‘unprecedented’ wave of launches
February 9, 2007Sales and Marketing
Novartis is preparing to set a new record for the pharmaceutical industry by launching eight products in the next 12 …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
